This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Obesity and coronary heart disease

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • waist circumference is the most practical marker for abdominal obesity
    • overweight and abdominal obesity are associated with other cardiovascular risk factors including small and dense atherogenic LDL cholesterol, low HDL cholesterol, raised triglycerides, elevated blood pressure, insulin resistance, and impaired glucose regulation including diabetes
    • weight reduction results in a lower blood pressure, lower LDL cholesterol and triglycerides, higher HDL cholesterol, and an improvement in hyperinsulinaemia and hyperglycaemia (1)
  • obese women have four times the risk of CHD than non-obese women (2)
  • in men being obese (BMI >30) or overweight is strongly associated with an increase in the risk of atherosclerotic disease (3)
  • a cohort study revealed that the adverse effects of overweight on blood pressure and cholesterol levels could account for about 45% of the increased risk of CHD (4)
  • NICE state that severe obesity (body mass index greater than 40 kg/m2) affects CVD risk and should be considered when using risk scores to inform treatment decisions (5)

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.